Efficacy and Safety of a Quadruple Ultra-low-dose Treatment for Hypertension

NCT03640312 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

62

Enrollment

OTHER

Sponsor class

Conditions

Hypertension

Interventions

DRUG: QUARTET LDQT
DRUG: Candesartan

Sponsor

Washington University School of Medicine

Collaborators

[object Object]
[object Object]